Antiatherosclerotic effects of calcium channel blockers
- 1 August 1992
- journal article
- review article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 92 (2) , 265-268
- https://doi.org/10.1080/00325481.1992.11701430
Abstract
Conventional treatment of hypertension has done little to reduce mortality from coronary artery disease. In fact, some of the antihypertensive agents routinely prescribed appear to be atherogenic. In this article, Dr Sowers suggests that in addition to life-style changes and use of lipid-lowering agents, certain calcium channel blockers may inhibit the atherosclerotic process in hypertensive patients. Using the results of animal and human studies, he describes the antiatherogenic mechanisms of these agents.Keywords
This publication has 7 references indexed in Scilit:
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Can lifestyle changes reverse coronary heart disease?: The Lifestyle Heart TrialPublished by Elsevier ,1990
- Insulin Resistance, Glucose Intolerance and Hyperinsulinemia in Patients with HypertensionAmerican Journal of Hypertension, 1989
- Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass graftsJAMA, 1987
- Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110.Circulation Research, 1986
- Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbitThe American Journal of Cardiology, 1984
- Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.Journal of Clinical Investigation, 1981